GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Statera Biopharma STAB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Statera Biopharma — daily STAB Delayed
Market value
$14,284
Last close × shares
Volume
3k
Shares, 6 Nov 2026

About Statera Biopharma

Its shares trade under the ticker STAB. It has been listed since 21 July 2006. In the fiscal year to 31 December 2021, it reported revenue of $1.5m and a net loss of $101.8m. At that date it held total assets of $21.2m and shareholders' equity of −$1.6m.

Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is headquartered in Fort Collins, Colorado. The company went IPO on 2006-07-21. The firm is focused on developing immunotherapies autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. The company has platform of toll-like receptor (TLR) agonists with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532. The firm is developing therapies designed to directly elicit within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. The company has clinical programs for Crohn’s disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401) and COVID-19 (STAT-205) in addition to potential expansion into fibromyalgia and multiple sclerosis.

Figures and description from our data supplier, not checked against the company's own report.

More about Statera Biopharma →

Latest on Statera Biopharma

Our reporting

We have not reported on Statera Biopharma yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Statera Biopharma's ticker?

Statera Biopharma trades as STAB on its US listing, under ISIN US8575611046.

What was Statera Biopharma's last closing price?

0.00 on 6 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.